Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Barr Laboratories
Approval Status: Approved October 1997
Treatment for: post-menopausal osteoporosis

General Information

Estradiol Tablets, the generic equivalent of Bristol Myers Squibb's Estrace, has been approved for marketing. Barr's Estradiol will be available in .5, 1, and 2 mg strengths. Estradiol is used to treat moderate to severe vasomotor symptoms associated with menopause as well as for the prevention of osteoporosis.